20 / 60
18
SCIENTIFIC PROGRAMME
| PROGRAMME & EXHIBITION GUIDE
Outcomes following unilateral neck irradiation for oropharyngeal cancer
stratified by HPV status
J. Waldron (Canada), S. Huang, J. Kim, A. Bayley, J. Ringash, A. Hope,
M. Giuliani, J. Cho, L. Tong, B. O’Sullivan
PD-035
Association of HPV/p16 status with efficacy and safety in patients with
OPC in the phase 3 RT/cetuximab registration trial
J.A. Bonner (USA), P.M. Harari, J. Giralt, D. Bell, D. Raben, J. Liu,
J. Schulten, K.K. Ang, D.I. Rosenthal
PD-036
14:44 Discussant: L. Siu (Canada)
Prospective randomised adaptive dose-de-escalation-trial for the elective
neck: acute toxicity and control
F. Duprez (Belgium), D. Berwouts, D. Nevens, S. Nuyts, W. De Neve
PD-037
Risk factors for recurrence after carbon ion therapy for adenoid cystic
carcinoma: impact of the histologic subtypes
H. Ikawa (Japan), M. Koto, A. Hasegawa, R. Takagi, K. Naganawa,
T. Takenouchi, H. Tsuji, T. Kamada
PD-038
Patterns of long-term swallowing dysfunction after definitive radiotherapy
or chemoradiation
M. Christianen (The Netherlands), I.M. Verdonck-de Leeuw, P. Doornaert,
O. Chouvalova, R.J.H.M. Steenbakkers, R. Leemans, S. Oosting, B.J. Slotman,
H.P. Bijl, J.A. Langendijk
PD-039
15:06 Discussant: M. Sen (United Kingdom)
Proffered papers
SESSION 2
16:00 - 17:00
Chair: H. Langendijk (The Netherlands)
Chair: A. Mäkitie (Finland)
16:00 Hypopharynx carcinoma - the influence of IMRT and concurrent chemo-
therapy
T. Hermanrud (Denmark), M. Farhadi, C. Boje, C.D. Madsen, K. Nowicka-
Matus, J. Johansen, E. Andersen, H. Primdahl, M. Andersen, J. Friborg
OC-040